Search Results

1 - 10 of 34 items :

  • "management" x
  • Paediatric Haematology and Oncology x
Clear All
Diagnosis and management of complications of chronic lymphocytic leukemia/small lymphocytic lymphoma

complications for CLL appear to be increased by regimens including idelalisib. Combination therapy clinical trials including idelalisib were halted by the Federal Drug Administration and European Drug Agency because of concerns for excess toxicity including increased rates of PJP and CMV infections [ 29 ]. There are limited data on the effect of duvelisib and umbralisib on risk of infection in CLL patients. Management Management of infection in CLL patients requires education of patients and care givers to respond rapidly to evidence of infection, appropriate

Open access
Postępowanie u pacjentek z nowotworem mieloproliferacyjnym BCR-ABL ujemnym w ciąży

ekspertów Hct powinien być dostosowany do normy obowiązującej w danym trymestrze ciąży (31-41% w I trymestrze, 30-38% w II trymestrze i 28-39% w III trymestrze) [ 16 ]. Nie jest wskazana suplementacja żelaza ze względu na ryzyko wzrostu parametrów czerwonokrwinkowych. Tabela II Terapia u pacjentki z nowotworem mieloproliferacyjnym w ciąży w zależności od czynników ryzyka [ 5 , 14 , 16 ] Table II. Management of pregnant women with myeloproliferative neoplasm according to risk factors [ 5 , 14 , 16 ] Ryzyko Terapia w trakcie ciąży Terapia w trakcie

Open access
ABC of viral infections in hematology: focus on herpesviruses

are ambiguous. The summary, based on large studies, is presented in table XI Conclusions Because of high worldwide seroprevalence and latency, infections with herpesviruses are, and will be, frequent. Current strategies of management of CMV and EBV are based on mandatory monitoring of DNA-emia and administration of preemptive therapy if DNA-emia is positive; however, pharmacological prophylaxis is a renewed possibility in case of CMV (letermovir) and is an option for EBV infection (rituximab). In case of HHV-6, no routine screening is recommended; however, in

Open access
Infectious complications in children and adults with hematological malignancies

transplantation patients: a surmountable challenge Hematology Am Soc Hematol Educ Program 2012 2012 265 70 [7] Ljungman P, de la Camara R, Cordonnier C, et al. European Conference on Infections in L: Management of CMV, HHV-6, HHV-7 and Kaposisarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 2008;42:227-40. 10.1038/bmt.2008.162 Ljungman P de la Camara R Cordonnier C et al European Conference on Infections in L: Management of CMV, HHV-6, HHV-7 and Kaposisarcoma herpesvirus (HHV-8

Open access
Wyzwania wczesnej diagnostyki szpiczaka plazmocytowego – algorytm diagnostyczny

Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies Am J Kidney Dis 2012 59 6 786 94 [28] Dimopoulos MA, Sonneveld P, Leung N, et al. International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment. J Clin Oncol 2016;34(13):1544–57. 10.1200/JCO.2015.65.0044 Dimopoulos MA Sonneveld P Leung N et al International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment J Clin Oncol 2016 34 13 1544

Open access
Strategie doboru krwinek czerwonych dla biorców w różnych sytuacjach klinicznych

.1365-3148.2012.01199.x Milkins C Berryman J Cantwell C et al Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories Transfus Med 2013 23 1 3 35 [6] Win N.: Guidelines for the management of urgent red cell transfusion and situations when serological compatibility cannot be assured. INFORMATION INF437/1.3. https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/14861/inf4373-guidelines-for-the-management

Open access
Chłoniak z komórek płaszcza – rola terapii celowanych

. Piśmiennictwo/References [1] Martin P, Ghione P, Dreyling M. Mantle cell lymphoma – Current standards of care and future directions. Cancer Treat Rev 2017;58:51-60. 10.1016/j.ctrv.2017.05.008 28651117 Martin P Ghione P Dreyling M Mantle cell lymphoma – Current standards of care and future directions Cancer Treat Rev 2017 58 51 60 [2] Vose JM. Mantle cell lymphoma: 2017 update on diagnosis, risk- stratification, and clinical management. Am J Hematol 2017;92:806- 13. 28699667 10.1002/ajh.24797 Vose JM Mantle cell lymphoma: 2017 update on

Open access
Diagnostic approach to light-chain cardiac amyloidosis and its differential diagnosis

] Collins, A.B., R.N. Smith, and J.R. Stone, Classification of amyloid deposits in diagnostic cardiac specimens by immunofluorescence . Cardiovasc Pathol, 2009. 18 (4): p. 205-16. 10.1016/j.carpath.2008.05.004 Collins A.B. Smith R.N. Stone J.R. Classification of amyloid deposits in diagnostic cardiac specimens by immunofluorescence Cardiovasc Pathol 2009 18 4 205 16 [19] Halwani, O. and D.H. Delgado, Cardiac amyloidosis : an approach to diagnosis and management . Expert Rev Cardiovasc Ther, 2010. 8 (7): p. 1007-13. 10.1586/erc.10.41 Halwani O. Delgado D.H. Cardiac

Open access
Opieka ginekologiczna po transplantacji komórek krwiotwórczych – zalecenia na podstawie piśmiennictwa i własnych doświadczeń

from the international consensus project on clinical practice in chronic GVHD Bone Marrow Transplant 2015 50 1 3 – 9 10.1038/bmt.2014.242 [5] Zantomio D, Grigg AP, MacGregor L, Panek-Hudson Y, Szer J, Ayton R. Female genital tract graft-versus-host disease: Incidence, risk factors and recommendations for management. Bone Marrow Transplant 2006; 38(8):567–72. 10.1038/sj.bmt.1705487 Zantomio D Grigg AP MacGregor L Panek-Hudson Y Szer J Ayton R Female genital tract graft-versus-host disease: Incidence, risk factors and recommendations for

Open access
Implantoprosthetic rehabilitation of a patient with severe form of hemophilia B: a case report

treatment for hemophilia B is based on two types of FIX concentrates, plasma derived and recombinant, obtained through genetic engineering techniques [ 5 ]. Hemostasis management should be planned for dental extraction or surgical procedures performed within the oral cavity of patients with severe hemophilia B; in addition, an hematologist should also be consulted and FIX substitution provided. Prophylaxis against bleeding related to other surgical or dental procedures also includes the use of antifibrinolytic agents, such as tranexamic acid and e-aminocaproic acid, both

Open access